HomeIndustriesHealthcareBeta Bionics (BBNX) CEO on Advanced Diabetes Treatment & IPO

Beta Bionics (BBNX) CEO on Advanced Diabetes Treatment & IPO

Sean Saint, CEO of Beta Bionics (BBNX), discusses the company’s IPO today and what the company does. Beta Bionics’ “bionic pancreas” is “the most automated” system to help control diabetes on the market, he says. He discusses why the system is better than regular insulin pumps, including its ability to learn and adapt, and how patients can access it.

Morning Trade Live

30 Jan 2025

SHARE

ON AIR
11:00 pm
Next Gen Investing
replay
education
12:00 am
Your First Trade
REPLAY
education
12:30 am
Your First Trade
REPLAY
1:00 am
The Wrap
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Market Overtime
REPLAY
4:00 am
Market Overtime
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Inside the Mind of a Trader
REPLAY
6:00 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
7:00 pm
Market Overtime
REPLAY
8:00 pm
The Wrap
REPLAY
9:00 pm
Market Overtime
REPLAY
10:00 pm
Fast Market
REPLAY
ON AIR
11:00 pm
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor